Physician profile
Gregory Greer
NPI 1235576695
$3,293.87
in general payments reported to CMS, 2019-2025
39 companies · $954 in 2025
The $954 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $159 · 2021: $324 · 2022: $356 · 2023: $717 · 2024: $561 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,232.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $481.14 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $473.92 | 2019-2025 | |
| Novo Nordisk INC | $380.79 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $314.18 | 2019-2024 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.83 | 2020-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.36 | 2023-2025 | Ofev, Jardiance, Jascayd |
| Astrazeneca Pharmaceuticals Lp | $111.01 | 2019-2025 | Breztri, Flumist Quadrivalent |
| Sumitomo Pharma America, INC. | $110.07 | 2023-2025 | Gemtesa |
| Dexcom, INC. | $89.50 | 2023-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $86.66 | 2019-2024 | |
| Vanda Pharmaceuticals INC. | $74.54 | 2025 | Fanapt |
| Medtronic, INC. | $73.15 | 2022-2025 | Intellis Adaptivestim |
| Abbvie INC. | $72.78 | 2021-2025 | |
| Gilead Sciences, INC. | $63.70 | 2024 | |
| Abbott Laboratories | $60.49 | 2022-2025 | Freestyle Libre 3 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.